Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weichang'an
- Development stage
- Unknown
- Lead developer
- State Administration of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Weichang'an is a traditional Chinese medicine (TCM) herbal formula used primarily for gastrointestinal disorders. It is most commonly indicated for diarrhoea-predominant irritable bowel syndrome (IBS-D), where it has been shown to alleviate symptoms by modulating the cyclic adenosine monophosphate (cAMP) signaling pathway[1]. The formula also demonstrates anti-inflammatory, antibacterial, and antiviral properties[3], and has been studied for its effects on ulcerative colitis and constipation[4][6]. In oncology research, Weichang'an has shown potential in inhibiting tumor growth in gastric and colorectal cancer models by inducing mitochondrial apoptosis in cancer cells through modulation of proteins such as Bcl-2 family members and caspases[2][5]. Its mechanisms include regulation of cell proliferation, apoptosis induction via mitochondrial pathways, inhibition of STAT3 signaling in tumors, and improvement of gastrointestinal motility.
- Brand names
- Weichang'an
- Other names
- WeiChang'An PillWeichang'an formulaWei Chang An pill
02
Targets
CASP (Caspase family)STAT3 (Signal Transducer and Activator of Transcription 3)BCL-2 (BCL-2 family)
Beyond the preview
Go deeper on Weichang'an.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Weichang'an.